https://newsletter.en.creamermedia.com
Africa|Health|Innovation|Installation|Manufacturing|Packaging|Training|Equipment|Manufacturing |Packaging|Operations
Africa|Health|Innovation|Installation|Manufacturing|Packaging|Training|Equipment|Manufacturing |Packaging|Operations
africa|health|innovation|installation|manufacturing|packaging-company|training|equipment|manufacturing-industry-term|packaging|operations

Pfizer/BioNTech strike South Africa COVID-19 manufacturing deal with Biovac

21st July 2021

By: Reuters

  

Font size: - +

Pfizer Inc and BioNTech SE on Wednesday said they had struck a deal for South Africa's Biovac Institute to process and distribute over 100 million doses a year of their Covid-19 vaccine for the African Union beginning in 2022.

Technical transfer, on-site development and equipment installation activities will begin immediately, they said. Biovac, a public-private partnership focused on vaccine production, will receive Covid-19 vaccine drug substance made in plants in Europe, and will begin so-called fill-finish operations, the last stage of drug manufacturing and packaging, in 2022.

Pfizer announced the partnership ahead of a speech by Chief Executive Albert Bourla at a World Trade Organization (WTO) Summit.

WTO members have been in talks for months on waiving drug firms' intellectual property (IP) rights for Covid-19 vaccines. Most developing countries support the waiver but several wealthy countries remain strongly opposed, saying it will deter research that allowed Covid-19 vaccines to be produced so quickly.

In his prepared remarks, Bourla made a plea for the group to maintain the current IP rules.

"Weakening IP rules will only discourage the type of unprecedented innovation which brought vaccines forward in record time and make it harder for companies to collaborate going forward," Bourla said.

Last month, the World Health Organization said it was setting up a hub, or training facility, in South Africa to give companies there the know-how and licenses to produce Covid-19 vaccines. Biovac was one of the initial participants in the hub.

Biovac has partnered with Pfizer since 2015 to manufacture and distribute its Prevenar 13 pneumonia vaccine.

Edited by Reuters

Comments

Showroom

ESAB showroom image
ESAB South Africa

ESAB South Arica, the leading supplier of high-end welding and cutting products to the Southern African industrial market is based in...

VISIT SHOWROOM 
Weir
Weir

Weir Minerals Europe, Middle East and Africa is a global supplier of excellent minerals solutions, including pumps, valves, hydrocyclones,...

VISIT SHOWROOM 

Latest Multimedia

sponsored by

Photo of Martin Creamer
On-The-Air (15/11/2024)
15th November 2024 By: Martin Creamer

Option 1 (equivalent of R125 a month):

Receive a weekly copy of Creamer Media's Engineering News & Mining Weekly magazine
(print copy for those in South Africa and e-magazine for those outside of South Africa)
Receive daily email newsletters
Access to full search results
Access archive of magazine back copies
Access to Projects in Progress
Access to ONE Research Report of your choice in PDF format

Option 2 (equivalent of R375 a month):

All benefits from Option 1
PLUS
Access to Creamer Media's Research Channel Africa for ALL Research Reports, in PDF format, on various industrial and mining sectors including Electricity; Water; Energy Transition; Hydrogen; Roads, Rail and Ports; Coal; Gold; Platinum; Battery Metals; etc.

Already a subscriber?

Forgotten your password?

MAGAZINE & ONLINE

SUBSCRIBE

RESEARCH CHANNEL AFRICA

SUBSCRIBE

CORPORATE PACKAGES

CLICK FOR A QUOTATION







sq:0.094 0.195s - 195pq - 2rq
Subscribe Now